Skip to main content

Menu
  • Home
  • News
    • News Blog
    • Video CE-MS Technology
  • About Us
    • Mosaiques Group
    • Scientific Advisory Board
    • Vision
    • Prof. Harald Mischak
    • Dr. Agnieszka Latosinska
    • Team Mosaiques
  • Research and Development
    • Technology
      • Clinical Proteomics
    • Areas
      • Cardiovascular Diseases
      • Inflammatory diseases
      • Nephrology
        • Acute kidney injury
        • Chronic kidney disease
        • Pediatric Nephrology
      • Oncology
        • Bladder Cancer
        • Cholangiocarcinoma
        • Prostate Cancer
      • Transplantation
        • Graft-versus-Host Disease
        • Renal Transplant Rejection
    • Projects
  • Applications
    • Animal Models (rat or mice)
    • Clinical proteomic study design
    • Diagnostics
    • Drug Discovery
    • Drug Evaluation
    • Personalized Medicine
  • Publications
    • Scientific Articles
      • Publications 2023
      • Publications 2022
      • Publications 2021
      • Publications 2020
      • Publications 2019
      • Publications 2018
      • Publications 2017
      • Publications 2016
      • Publications 2015
      • Publications 2014
      • Publications 2013
      • Publications 2012
      • Publications 2011
      • Publications 2010
      • Publications 2009
      • Publications 2008
      • Publications 2007
      • Publications 2006
      • Publications 2005
      • Publications 2004
      • Publications 2003
  • Proteome Database
  • Contact
    • Sitemap
    • Imprint
    • privacy
Mosaiques Diagnostics | Protein Analysis for Clinical Diagnosis and Pharmaceutical ResearchDiagnostic ProductsHUMAN URINARY PROTEOME DATABASE

Protein Analysis for Clinical Diagnosis

and Pharmaceutical Research

Mosaiques diagnostics provides highly innovative Clinical Proteomics services for academic institutions and pharmaceutical companies. Mosaiques revolutionary CE-MS technology (capillary electrophoresis coupled to mass spectrometry) helps to diagnose severe diseases at an early development stage.

Diagnostic Products
Urin Tests

Precise and reliable detection of diseases in early stages allows prompt initiation of therapy and results in minimizing patients' burden

Explore our offer here

 

HUMAN URINARY PROTEOME DATABASE

A database of naturally occurring human urinary peptides and proteins for use in clinical applications

Disco-I project meeting in Toulouse

  • Read more about Disco-I project meeting in Toulouse
  • sysadmin's blog

Post (long) Covid-19 syndrome

  • Read more about Post (long) Covid-19 syndrome
  • sysadmin's blog

DisCo-I Project Training Course

  • Read more about DisCo-I Project Training Course
  • sysadmin's blog

The ProSTRAT-AI project has officially started!

  • Read more about The ProSTRAT-AI project has officially started!
  • sysadmin's blog

Mosaiques attend the multi-stakeholder hybrid workshop

  • Read more about Mosaiques attend the multi-stakeholder hybrid workshop
  • sysadmin's blog

Successful ReDiRECt project!

  • Read more about Successful ReDiRECt project!
  • sysadmin's blog

Study results available

  • Read more about Study results available
  • sysadmin's blog

Risk stratification in IgAN

  • Read more about Risk stratification in IgAN
  • sysadmin's blog

New funded ERAPerMed projects

  • Read more about New funded ERAPerMed projects
  • sysadmin's blog

Kick-Off meeting for ELMUMY Horizon Cancer Mission research programme

  • Read more about Kick-Off meeting for ELMUMY Horizon Cancer Mission research programme
  • sysadmin's blog

Pages

  • 1
  • 2
  • 3
  • next ›
  • last »

Latest News

 

DisCo-I Project project meeting

-

Post (long) Covid-19 syndrome

-

MULTIR project

-

MOSAIQUES NEWS BLOG

 

Latest Articles

Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation​.

Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients.

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy.

 

 

 

 

 

Funding

 

Contact Mosaiques

mosaiques diagnostics and therapeutics AG

Rotenburger Str. 20
D-30659 Hannover
Germany

Phone: +49 (0)511 55 47 44 0
Fax:     +49 (0)511 55 47 44 31

Services

 Diagnostic Products

 Scientific Articles

 Contact

Quick Links

 Site Map

 Areas

 International Network & Partners

 Technology

 Projects

News

FDA issues letter of support for
urinary peptide-based biomarker
to detect early stage of CKD.

 NEWS BLOG

 

Copyright © 2023,

Design by Zymphonies

  • Home
    • Index
  • Configuration
    • Search and metadata
      • Search settings
      • XML sitemap
        • Add new XML sitemap
        • Custom links
          • Add custom link
        • Search Engines
        • Settings
        • Rebuild links
  • Help
  • Log out
  • Hello Anonymous